Oral and Olfactory Complications of Recovered COVID-19 Patients
Launched by UNIVERSITY OF GIESSEN · Mar 9, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the oral and smell-related problems that some people experience after recovering from COVID-19. Researchers want to understand how long these symptoms last and if they are related to how severe the COVID-19 illness was. This study is important because it can help identify what causes these issues, which could lead to better treatments for those affected.
If you are an adult who has recovered from COVID-19 and it’s been at least three months since your illness, you may be eligible to participate in this study. However, individuals with certain conditions, like psychiatric or neurological diseases, or those who have had prior oral or nasal surgeries, won’t be included. Participants will undergo evaluations to assess their oral health and senses of taste and smell. This trial is currently recruiting, and all genders aged 18 and older are welcome to join. Your involvement could contribute valuable information to help others who are experiencing similar challenges after COVID-19.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult COVID-19 recovery patients (exceeding the age of 18) will be included in the study. The time between illness and study recruitment shall be at least 3 months.
- Exclusion Criteria:
- • Exclusion criteria are psychiatric or neurological diseases, previous trauma, surgery or radiotherapy in the oral or nasal cavities, pre-existing taste or smell dysfunctions or chronic rhinosinusitis.
About University Of Giessen
The University of Giessen, a prominent research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including medicine, pharmacology, and public health, to conduct rigorous studies aimed at improving patient outcomes. Committed to maintaining the highest ethical standards and regulatory compliance, the University of Giessen fosters a research environment that encourages scientific inquiry and the translation of findings into clinical practice, ultimately contributing to the advancement of healthcare and therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gießen, Hesse, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials